Symbol="VCEL"
AssetType="Common Stock"
Name="Vericel Corp Ord"
Description="Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="887359"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="64 SIDNEY ST., CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1805801000"
EBITDA="-13696000"
PERatio="None"
PEGRatio="0"
BookValue="4.083"
DividendPerShare="0"
DividendYield="0"
EPS="-0.36"
RevenuePerShareTTM="3.585"
ProfitMargin="-0.101"
OperatingMarginTTM="-0.106"
ReturnOnAssetsTTM="-0.0444"
ReturnOnEquityTTM="-0.0934"
RevenueTTM="169308000"
GrossProfitTTM="109788000"
DilutedEPSTTM="-0.36"
QuarterlyEarningsGrowthYOY="0.343"
QuarterlyRevenueGrowthYOY="0.137"
AnalystTargetPrice="40.75"
TrailingPE="-"
ForwardPE="370.37"
PriceToSalesRatioTTM="6.89"
PriceToBookRatio="6.38"
EVToRevenue="7.25"
EVToEBITDA="-70.31"
Beta="1.778"
num_52WeekHigh="39.9"
num_52WeekLow="17.3"
num_50DayMovingAverage="35.36"
num_200DayMovingAverage="29.28"
SharesOutstanding="47564900"
DividendDate="None"
ExDividendDate="None"
symbol="VCEL"
open="38.22"
high="38.44"
low="37.14"
price="37.52"
volume="466313.00"
latest_trading_day="2023-07-27"
previous_close="37.80"
change="-0.28"
change_percent="-0.7407%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="326830"
Change_recent_avg="0.04"
Delta_recent_avg="1.3"
Variance_recent_avg="0.65"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="520"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0085.jpeg"
image_negative_thumbnail_id_2="1135"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0168.jpeg"
image_neutral_thumbnail_id_1="550"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="704"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0004.jpeg"
image_positive_thumbnail_id_2="684"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
